Skip to main content
ADPT
NASDAQ Life Sciences

Officer Francis Lo Files Intent to Sell $4.27M in Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$22.764
Mkt Cap
$3.58B
52W Low
$9.955
52W High
$22.54
52W Position info
129% above low
Off High info
at 52W high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

ADPT has more than doubled off its 52-week low of $9.955.

Summary

An officer at Adaptive Biotechnologies has filed an intent to sell over $4 million in company stock, primarily from compensation, adding to recent insider selling activity.


Key Events · Ownership and Investor Activity · ADPT

  • Officer Files Intent to Sell Shares

    Officer Francis Lo has filed a Form 144 to sell 199,260 shares of common stock, valued at approximately $4.27 million. These shares were acquired through the exercise of stock options and vesting of restricted stock units.

  • Follows Recent Insider Sales

    This proposed sale by Mr. Lo follows previous sales of 62,305 shares totaling over $1 million in the past three months, and aligns with a broader pattern of insider distribution noted in recent activity.

  • Stock Trading Above 52-Week High

    The intent to sell comes as Adaptive Biotechnologies' stock is trading above its 52-week high of $22.54, potentially indicating profit-taking by the officer.


Analysis · ADPT · Life Sciences

Officer Francis Lo has filed a Form 144 indicating an intent to sell approximately $4.27 million worth of common stock. This proposed sale, primarily from exercised stock options and vested restricted stock units, follows previous sales by Mr. Lo and other insiders, contributing to a broader pattern of insider distribution. The filing occurs while the stock is trading above its 52-week high, suggesting profit-taking.

At the time of this filing, ADPT was trading at $22.76 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $9.96 to $22.54. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ADPT - Latest Insights

ADPT
Jul 01, 2026, 4:35 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $22.76
Real-time Price: $21.00 info
Change: -$1.76 (-8%) info
Market Cap: $3.364B info
ADPT
Jun 22, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $17.37
Real-time Price: $21.00 info
Change: +$3.63 (+21%) info
Market Cap: $3.364B info
ADPT
Jun 17, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $17.13
Real-time Price: $21.00 info
Change: +$3.87 (+23%) info
Market Cap: $3.364B info
ADPT
Jun 15, 2026, 4:50 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $16.50
Real-time Price: $21.00 info
Change: +$4.50 (+27%) info
Market Cap: $3.364B info
ADPT
Jun 15, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $15.97
Real-time Price: $21.00 info
Change: +$5.03 (+31%) info
Market Cap: $3.364B info
ADPT
Jun 15, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $15.90
Real-time Price: $21.00 info
Change: +$5.10 (+32%) info
Market Cap: $3.364B info
ADPT
May 29, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $15.19
Real-time Price: $21.00 info
Change: +$5.81 (+38%) info
Market Cap: $3.364B info
ADPT
May 05, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $15.70
Real-time Price: $21.00 info
Change: +$5.30 (+34%) info
Market Cap: $3.364B info
ADPT
May 05, 2026, 4:27 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $16.00
Real-time Price: $21.00 info
Change: +$5.00 (+31%) info
Market Cap: $3.364B info
ADPT
May 05, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.00
Real-time Price: $21.00 info
Change: +$6.00 (+40%) info
Market Cap: $3.364B info